231 related articles for article (PubMed ID: 34827663)
1. LncRNAs: Novel Biomarkers for Pancreatic Cancer.
Ghafouri-Fard S; Fathi M; Zhai T; Taheri M; Dong P
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827663
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNAs: role and contribution in pancreatic cancer.
Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP
Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review.
Momtazmanesh S; Rezaei N
Front Oncol; 2021; 11():712786. PubMed ID: 34322395
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer.
Xie W; Chu M; Song G; Zuo Z; Han Z; Chen C; Li Y; Wang ZW
Semin Cancer Biol; 2022 Aug; 83():303-318. PubMed ID: 33207266
[TBL] [Abstract][Full Text] [Related]
5. lncRNA Biomarkers of Glioblastoma Multiforme.
Pokorná M; Černá M; Boussios S; Ovsepian SV; O'Leary VB
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790894
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
[TBL] [Abstract][Full Text] [Related]
7. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
[TBL] [Abstract][Full Text] [Related]
8. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma.
Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW
Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
10. The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers.
Ma C; Shi X; Zhu Q; Li Q; Liu Y; Yao Y; Song Y
Tumour Biol; 2016 Feb; 37(2):1437-44. PubMed ID: 26634743
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer.
Chen P; Wan D; Zheng D; Zheng Q; Wu F; Zhi Q
Biomed Pharmacother; 2016 Oct; 83():1220-1226. PubMed ID: 27562722
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific up-regulation of lncRNAs in peripheral blood of patients with schizophrenia.
Fallah H; Azari I; Neishabouri SM; Oskooei VK; Taheri M; Ghafouri-Fard S
Sci Rep; 2019 Sep; 9(1):12737. PubMed ID: 31484957
[TBL] [Abstract][Full Text] [Related]
13. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-3924.
Pan S; Shen M; Zhou M; Shi X; He R; Yin T; Wang M; Guo X; Qin R
Cell Death Dis; 2019 Nov; 10(12):883. PubMed ID: 31767833
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs: From disease code to drug role.
Chen Y; Li Z; Chen X; Zhang S
Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
[TBL] [Abstract][Full Text] [Related]
16. The regulatory roles of long noncoding RNAs in the biological behavior of pancreatic cancer.
Li Y; Yang X; Kang X; Liu S
Saudi J Gastroenterol; 2019; 25(3):145-151. PubMed ID: 30720003
[TBL] [Abstract][Full Text] [Related]
17. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer.
Giulietti M; Righetti A; Principato G; Piva F
Carcinogenesis; 2018 Jul; 39(8):1016-1025. PubMed ID: 29796634
[TBL] [Abstract][Full Text] [Related]
18. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.
Zheng QX; Wang J; Gu XY; Huang CH; Chen C; Hong M; Chen Z
Biomed Pharmacother; 2021 Mar; 135():111169. PubMed ID: 33433359
[TBL] [Abstract][Full Text] [Related]
19. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
